BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 27, 2024
See today's BioWorld Asia
Home
» Wuxi delivers a solid first quarter despite China's macroeconomic woes
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Wuxi delivers a solid first quarter despite China's macroeconomic woes
May 21, 2014
By
Cornelia Zou
No Comments
HONG KONG – Powered by sales of biologics and other pharmaceutical products, Wuxi Pharmatech Inc. posted strong first quarter results hurt only by a depreciation in the Chinese RMB.
BioWorld Asia
